David Eberhard MD

David Eberhard, MD, PhD, is an accomplished pathologist and scientist specializing in oncology, with extensive experience in translational and basic research, drug development, and precision medicine strategies. They served as Chief Medical Pathologist at Flagship Biosciences, as well as Chief Medical Officer at Inivata, and have held various consulting roles, including a current position at Natera. David's academic background includes a B.S. in Biology from the University of South Dakota and an MD-PhD from the University of Michigan Medical School. They have been an influential figure in cancer genomics and molecular pathology across both industry and academia.